Lauren S Franks, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1238 N Highway 7, Sparkman, AR 71763 Phone: 870-678-3326 |
News Archive
It's the third deadliest cardiovascular diagnosis, but doctors are still often stumped to explain why 40% of patients experience unprovoked venous thromboembolism. And after a patient has dealt with these dangerous blood clots once, a second and subsequent events become much more likely.
Oncothyreon Inc. today announced enrollment of the first patient in a Phase 1/2 trial of PX-866 in combination with the chimeric monoclonal antibody cetuximab (Erbitux®). PX-866 is a small molecule compound designed to inhibit the activity of phosphatidylinositol-3-kinase (PI-3K), a component of an important cell survival signaling pathway.
A study by an international research group identified 15 novel biomarkers that are linked to late-onset dementias. These biomarkers are proteins, which predict cognitive decline and subsequent increased risk of dementia already 20 years before the disease onset.
Summer means more hours of daylight and for many, it contributes to trouble falling asleep. More than 40 million Americans suffer from chronic sleep disorders, resulting in $18 billion in cost to employers due to sleep loss issues.
› Verified 9 days ago